about
Systemic antibiotic therapy for chronic osteomyelitis in adultsPredisposing factors for recurrence of chronic posttraumatic osteomyelitis: a retrospective observational cohort study from a tertiary referral center in Brazil.Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort studyBaseline hypovitaminosis D is not associated with poor clinical outcomes in osteoarticular infectionsBiofilms and persistent wound infections in United States military trauma patients: a case-control analysisDuration of post-surgical antibiotic therapy for adult chronic osteomyelitis: a single-centre experience.Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort studyA retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureusDifferences in the Clinical Outcome of Osteomyelitis by Treating Specialty: Orthopedics or Infectology.Experience with community-based amphotericin B infusion therapy.A modified staging system for chronic osteomyelitisTeicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.Temporal changes in the prevalence and associates of diabetes-related lower extremity amputations in patients with type 2 diabetes: the Fremantle Diabetes StudyInoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections.Daptomycin versus vancomycin for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA): a nested case-control study.Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia.Outpatient parenteral antimicrobial therapy with ceftriaxone, a review.Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn.Optimal Duration of Antibiotic Therapy in Patients With Hematogenous Vertebral Osteomyelitis at Low Risk and High Risk of Recurrence.Infection after fracture osteosynthesis - Part I.Increased risk of chronic osteomyelitis after hip replacement: a retrospective population-based cohort study in an Asian population.Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting.Antibiotic cement-coated locking plate as a temporary internal fixator for femoral osteomyelitis defects.Use of erythrocyte sedimentation rate and C-reactive protein to predict osteomyelitis recurrence.Systemic antimicrobial therapy in osteomyelitisCeftobiprole: First reported experience in osteomyelitis.Chronic osteomyelitis management in austere environments: the International Committee of the Red Cross experience.Case Report: Rare occurrence of Pseudomonas aeruginosa osteomyelitis of the right clavicle in a patient with IgA nephropathy.Appropriate oral antibiotics for bone and joint infections based on the susceptibility of clinical Staphylococcus aureus isolates.Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureus.Unusual manifestations of vertebral osteomyelitis: intraosseous lesions mimicking metastases.Dehydroepiandosterone induction of increased resistance to vancomycin in Staphylococcus aureus clinical isolates (MSSA, MRSA).Outpatient parenteral antimicrobial therapy.Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.Osteomyelitis
P2860
Q28714211-DE69B1C6-D711-4D20-8DB4-981652AD8240Q33759244-5A98DD7D-BA97-47EC-91CD-3CCAD9EAAF24Q34100226-E5709C90-ADCF-4AB4-9BC9-EDBF66D6E0C4Q34519245-B46D660B-684D-4FDC-9F38-4898B4AD3234Q34524371-AD69AD34-6F37-4841-B3C7-EA5FF153217FQ35355026-0482C996-B2FB-4650-92D2-A3AAB6130E8FQ35391386-EBCCEFD5-14B7-4F14-B34C-1EFFD1E9363CQ35745670-0A5A4855-52A0-4967-A788-F262F8D7A5DCQ35871795-EC1EBC86-2B41-4181-9352-CBF54FA8CF91Q36130619-3AA06031-D0A6-425C-A856-5CD128A006C8Q36149247-9993F7C2-8407-4D44-9D12-D5C1FD45DDE3Q36181397-C8E935C1-1661-40EC-A910-E66DD0DA37B1Q36383377-5388F2C9-0138-4B53-B44F-B0FDDC51876DQ36666985-12DBF23D-3F5B-4F4A-9BC3-5D1472782F97Q36965812-BB1D6FD9-C136-4FEF-A3C8-15EDC081E084Q37639364-37B42358-22A2-4804-910A-5BA2AE8ABAD5Q37821604-11126D7E-EA2A-4A5F-B035-6DD35CEBE781Q37955286-23A82A0D-9BCE-43BA-B0BA-545DAC12ACABQ38004886-8F160394-1811-4433-8A5C-05F0002BA6A2Q38089918-ECAB10D9-A44E-4652-B904-333FE552B812Q38751083-83180C84-CD8E-4E7A-9386-5A9C62E2D287Q39142395-DEDF4180-B26E-4EA0-8C11-284DFEB8F6C1Q39193487-3C1AE006-C15C-4D6D-A334-A4EFE4F8344EQ39200930-FD786AA0-6D4F-4363-8B6D-EA3AAA8904F0Q39589461-961E45DE-86C3-4181-BCA3-0C30BC658A30Q40577509-BC30B778-0F1B-49CF-8DB5-5F2D7520B2A3Q40696014-59A7AAAD-E0A2-40F9-BF43-B366C04E76EBQ41034745-A96EABCC-FF35-48FB-9C55-4E35F7A12D38Q42412528-0718879F-2BF1-445B-8C6A-378427131896Q42652541-515D3309-419C-4918-AFB6-452B956B2321Q43077845-6C1D5EF4-A0DC-46FB-887D-AC03A88AE79FQ43159215-B98B52E9-3F2B-4DB6-A113-F7C613351419Q43183402-C1F2F81E-1BAF-4E01-B17A-7B3A29E2770CQ45120150-2D72C895-97D9-47C1-B762-211D7CC7E1CBQ45307997-46FCF8DE-B247-4A99-B7EE-ADBABBE5F36FQ50121508-E6884CEE-20F5-4EC5-B6E5-535214E53058Q50981134-BC561D6B-0A8C-4E3D-BC0D-B8E8BF63E742Q55109673-DEB3C91F-9E80-409E-A391-F04BA66F3CF6
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Risk factors and treatment outcomes in osteomyelitis.
@en
Risk factors and treatment outcomes in osteomyelitis.
@nl
type
label
Risk factors and treatment outcomes in osteomyelitis.
@en
Risk factors and treatment outcomes in osteomyelitis.
@nl
prefLabel
Risk factors and treatment outcomes in osteomyelitis.
@en
Risk factors and treatment outcomes in osteomyelitis.
@nl
P2093
P356
P1476
Risk factors and treatment outcomes in osteomyelitis.
@en
P2093
Alan D Tice
David A Shoultz
Pamela A Hoaglund
P304
P356
10.1093/JAC/DKG186
P407
P577
2003-03-28T00:00:00Z